Literature DB >> 11756978

Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types.

Paul K S Chan1, Alexander R Chang, Jo L K Cheung, Denise P C Chan, L Y Xu, Nelson L S Tang, Augustine F Cheng.   

Abstract

This cross-sectional survey assessed the determinants of human papillomavirus (HPV) infections among 2080 women who participated in cervical cancer screening. HPVs were typed by restriction and sequencing analyses. The prevalence of HPV was 7.3% (4.2% for high-risk, 1.9% for low-risk, and 2.1% for unknown-risk types). High-risk HPV prevalence decreased with age, whereas low- and unknown-risk HPVs had a second peak in older women. Young age was the only common variable associated with the 3 groups of HPV infections. Lifetime number of sex partners was associated with high- and low-risk types but not with unknown-risk HPVs. Previous Pap smear, treatment for cervical lesions, induced abortion, smoking and having smoker(s) in the family were risk factors for high-risk HPVs. Barrier contraception was protective for low-risk HPVs; current vaginal discharge had a negative association with unknown-risk HPVs. The results indicate that different risk profiles exist for infections with different HPV groups.

Entities:  

Mesh:

Year:  2001        PMID: 11756978     DOI: 10.1086/338010

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Association of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intraepithelial lesions among women in Brazil.

Authors:  R T Simões; M A G Gonçalves; E A Donadi; A L Simões; J S R Bettini; G Duarte; S M Quintana; M W P Carvalho; E G Soares
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods.

Authors:  Gabriel M Leung; Pauline P S Woo; Sarah M McGhee; Annie N Y Cheung; Susan Fan; Oscar Mang; Thuan Q Thach; Hextan Y S Ngan
Journal:  J Epidemiol Community Health       Date:  2006-08       Impact factor: 3.710

Review 3.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

4.  Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population.

Authors:  K S Cuschieri; H A Cubie; M W Whitley; A L Seagar; M J Arends; C Moore; G Gilkisson; E McGoogan
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

5.  Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus.

Authors:  Shui-Lian Yu; Paul K S Chan; Chun-Kwok Wong; Cheuk-Chun Szeto; Suzanne C Ho; Karine So; May M Y Yu; So-Fan Yim; Tak-Hong Cheung; Martin C S Wong; Jo L K Cheung; Apple C M Yeung; Edmund K Li; Lai-Shan Tam
Journal:  Arthritis Res Ther       Date:  2012-04-18       Impact factor: 5.156

6.  A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica.

Authors:  Megan Clarke; Mark Schiffman; Sholom Wacholder; Ana Cecilia Rodriguez; Allan Hildesheim; Wim Quint
Journal:  BMC Infect Dis       Date:  2013-07-08       Impact factor: 3.090

7.  Prevalence and risk factors of Human Papillomavirus (HPV) infection in southern Chinese women - a population-based study.

Authors:  Stephanie Si Liu; Kelvin Yuen Kwong Chan; Rebecca Ching Yu Leung; Karen Kar Loen Chan; Kar Fai Tam; May Hiu Mei Luk; Sue Seen Tsing Lo; Daniel Yee Tak Fong; Annie Nga Yin Cheung; Zhong Qiu Lin; Hextan Yuen Sheung Ngan
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

8.  Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.

Authors:  Colomba Giorgi; Paola Di Bonito; Felicia Grasso; Stefania Mochi; Luisa Accardi; Maria Gabriella Donà; Margherita Branca; Silvano Costa; Luciano Mariani; Alberto Agarossi; Marco Ciotti; Kari Syrjänen
Journal:  Infect Agent Cancer       Date:  2008-06-26       Impact factor: 2.965

9.  Differences in Factors Associated With High- and Low-Risk Oral Human Papillomavirus Genotypes in Men.

Authors:  Deepti Bettampadi; Brittney Dickey; Martha Abrahamsen; Bradley Sirak; Maria Luiza Baggio; Lenice Galan; Roberto Carvalho Silva; Luisa Villa; Eduardo Lazcano Ponce; Anna R Giuliano
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 5.226

10.  Baseline assessment of prevalence and geographical distribution of HPV types in Chile using self-collected vaginal samples.

Authors:  Catterina Ferreccio; Alejandro Corvalán; Paula Margozzini; Paola Viviani; Claudia González; Ximena Aguilera; Patti E Gravitt
Journal:  BMC Public Health       Date:  2008-02-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.